Predictive Oncology Inc (NAS:POAI)
$ 0.746 0.06 (8.75%) Market Cap: 4.97 Mil Enterprise Value: 4.29 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 55/100

Q4 2018 Precision Therapeutics Inc Earnings Call Transcript

Apr 01, 2019 / 08:30PM GMT
Operator

Good afternoon and welcome to the Precision Therapeutics Earnings Conference Call for the Year Ended December 31, 2018.

(Operator Instructions) Participants of this call are advised that the audio of this conference call is being broadcast live over the Internet and is also being recorded for playback purposes. A replay of the call will be available approximately 1 hour after the end of the call, through July 31, 2019.

I would now like to turn the conference call over to Scott Gordon, President of CORE IR, the company's investors -- investor relations firm.

Sir, please go ahead.

Scott Gordon
Core Ir - Co-Founder, President & Editor-In-Chief

Thank you, Jamie. And thank you all for joining today's conference call to discuss Precision Therapeutics' corporate developments and financial results for the year ended December 31, 2018.

With us today are Dr. Carl Schwartz, the company's Chief Executive Officer; and Bob Myers, the company's Chief Financial Officer.

After the close of the market today, Precision

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot